IFG Advisory’s Enzo Biochem, Inc. ENZ Stock Holding History

IFG Advisory’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,250	Closed	-$39.5K	–	516
2023 Q1	$39.5K	Buy	+16,250	New	+$24.2K	﹤0.01%	506

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IFG Advisory's ENZ Position: Q2 2023 in Review

IFG Advisory sold out of Enzo Biochem, Inc. (ENZ) in Q2 2023, closing a stake of 16,250 shares — an estimated $39.5K sold.

IFG Advisory first reported a position in ENZ in Q1 2023 and held it in 1 quarter. The position peaked at $39.5K in Q1 2023. 47 funds tracked by Wall St. Rank hold ENZ as of Q2 2023.

IFG Advisory reported no remaining Enzo Biochem, Inc. position as of Q2 2023 after selling out during the quarter.
IFG Advisory sold 16,250 Enzo Biochem, Inc. shares in Q2 2023, an estimated $39.5K.
IFG Advisory first reported a position in Enzo Biochem, Inc. in Q1 2023 and held it in 1 quarter.
IFG Advisory's Enzo Biochem, Inc. position peaked at $39.5K in Q1 2023.
47 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2023.

Based on IFG Advisory's 13F filing for Q2 2023, filed 21 Jul 2023.